These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17932340)

  • 21. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Foxp3 protein expression in porcine T lymphocytes.
    Käser T; Gerner W; Hammer SE; Patzl M; Saalmüller A
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):92-101. PubMed ID: 18565594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
    Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
    Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
    Kelley TW; Pohlman B; Elson P; Hsi ED
    Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.
    Merlo A; Tagliabue E; Mènard S; Balsari A
    Immunol Lett; 2008 Apr; 117(1):106-13. PubMed ID: 18295349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foxp3 as a marker of tolerance induction versus rejection.
    Zhang GY; Hu M; Wang YM; Alexander SI
    Curr Opin Organ Transplant; 2009 Feb; 14(1):40-5. PubMed ID: 19337145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
    Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
    J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From Ipex to foxp3: a new contribution of pediatrics to the understanding of the immune system].
    Marabelle A; Meyer M; Demeocq F; Lachaux A
    Arch Pediatr; 2008 Jan; 15(1):55-63. PubMed ID: 18155891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transcription factor FOXP3 and reproduction].
    Xia XY; Zhou X; Huang YF
    Zhonghua Nan Ke Xue; 2009 Jul; 15(7):642-5. PubMed ID: 19694382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of immunosenescence in cancer development.
    Fulop T; Kotb R; Fortin CF; Pawelec G; de Angelis F; Larbi A
    Ann N Y Acad Sci; 2010 Jun; 1197():158-65. PubMed ID: 20536845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do tumors actively escape from host immunosurveillance?
    Wilczyński JR; Duechler M
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):435-48. PubMed ID: 20922572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXP3+ regulatory T cells as biomarkers in human malignancies.
    Bignone PA; Banham AH
    Expert Opin Biol Ther; 2008 Dec; 8(12):1897-920. PubMed ID: 18990077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of FOXP3 in Human Cancers.
    Szylberg Ł; Karbownik D; Marszałek A
    Anticancer Res; 2016 Aug; 36(8):3789-94. PubMed ID: 27466478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do tumor stem cells actively escape from host immunosurveillance?
    Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
    Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricks tumors use to escape from immune control.
    Whiteside TL
    Oral Oncol; 2009 Oct; 45(10):e119-23. PubMed ID: 19467917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous tumor rejection in humans: trimming the myths.
    Wang E; Panelli M; Marincola FM
    Immunol Invest; 2006; 35(3-4):437-58. PubMed ID: 16916761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic techniques to overcome antitumor anergy].
    Dall P
    Zentralbl Gynakol; 1999; 121(4):198-201. PubMed ID: 10355098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.